CompanyPrivateWatertown, MA

Corner Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

DNov 4Latest SEC filing

Form DOct 20$17M sold

November 2026

Corner Therapeutics files Form D for $48.3 million equity offering tied to AI3 Bio merger

Nov 4FinancingCorner Therapeutics, Inc